Summary
The protein tyrosine kinase (PTK) of human breast tumors classified as positive (TM +) or negative (TM -) according to their estrogen and progestin receptor levels was partially characterized with regard to its distribution, kinetic parameters, molecular size, and ability to phosphorylate endogenous mammary proteins. For both types of tumors, PTK activity depended upon the presence of Mn++ (2–5 mM) and/or Mg++ (10–20 mM). The activities, total (per g of tissue) and specific (per mg of protein), were similar for both types of tumors, and an average of 60% of activity was located in cytosolic fractions. The autoradiographic detection of alkali-resistant phosphoproteins after SDS-PAGE showed very similar patterns between corresponding fractions from both types of tumors. Upon gel filtration, two peaks of activity of apparent Mr 245 kDa (peak I) and 47 kDa (peak II) were observed. Peak II was found in both cytosols and extracts from particulate fractions, while peak I was present only in the latter fraction for both TM + and TM — tumors. The apparent Km's for ATP ranged from 4.1 to 6.6 µM, and from 11 to 34 µg/ml for the synthetic substrate poly [Glu80, Tyr20], at an optimal pH of 6.5–7.5. When endogenous alkali-resistant phosphorylation of peaks I and II was determined by autoradiography after SDS-PAGE, two major mammary proteins of Mr 60 and 45 kDa were phosphorylated by peak II and three, Mr 145, 74, and 62 kDa, by peak I. Thus, in TM + and TM — human breast cancer tissues, PTKs possess similar enzymatic and molecular properties. The Mr 47 kDa is present in both soluble and particulate fractions, while the Mr 245 kDa is only observed in the latter fraction.
References
Yarden Y, Ullrich A: Growth factor receptor tyrosine kinases. Ann Rev Biochem 57: 443–478, 1988
Sibley DR, Benovic JL, Caron MG, Lefkowitz RJ: Phosphorylation of cell surface receptors: A mechanism of regulating signal transduction pathways. Endocrine Rev 9: 38–56, 1988
Hatakeyama M, Taniguchi T: Dysregulation of growth factor-receptor system in cellular transformation. Jpn J Cancer Res (Gann) 79: 885–901, 1988
Hunter T, Cooper JA: Viral oncogenes and tyrosine phosphorylation. The Enzymes XVII: 191–245, 1986
Schlessinger J: Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol 103: 2067–2072, 1986
Lin M-F, Lee PL, Clinton ML: Characterization of tyrosyl kinase activity in human serum. J Biol Chem 260: 1582–1587, 1985
Gentleman S, Martensen TM, Digiovanna JJ, Chader, GJ: Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin. Biochim Biophys Acta 798: 53–59, 1984
Huhn RD, Posner MR, Rayter SI, Foulkes JG, Frackelton AR: Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues. Proc Natl Acad Sci USA 84: 4408–4412, 1987
Giordano S, Di Renzo MF, Ferracini R, Chiado-Piat L, Comoglio PM: p 145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line. Mol Cell Biol 8: 3510–3517, 1988
Smithgall TE, Yu G, Glazer RI: Identification of the differentiation-associated p 93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells. J Biol Chem 263: 15050–15055, 1988
Clari G, Brunati AM, Moret V: Partial purification and characterization of cytosolic tyr-protein kinase(s) from human erythrocytes. Eur J Biochem 175: 673–678, 1988
Telerman A, Amson R, Zakut-Houri R, Givol D: Identification of the human pim-1 gene product as a 33-kilodalton cytoplasmic protein with tyrosine kinase activity. Mol Cell Biol 8: 1498–1503, 1988
Fitzpatrick S, Brightwell J, Wittliff JL, Barrows GH, Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res 44: 3448–3453, 1984
Pekonen F, Partanen S, Mäkinen T, Rutanen E-M: Receptor for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343–1347, 1988
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182, 1987
Jacobs C, Rübsamen H: Expression of pp 60c-src protein kinase in adult and fetal human tissue: High activities in some sarcomas and mammary carcinomas. Cancer Res 43: 1696–1702, 1983
Dickson RB, Lippman ME: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Rev 8: 29–43, 1987
Hennipman A, Van Oirschot BA, Smits J, Rijksen G, Staal GEJ: Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res 49: 516–521, 1989
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976
Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672, 1949
Nakamura S, Braun S, Racker E: A tyrosine protein kinase from Ehrlich ascites tumor cells. Arch Biochem Biophys 252: 538–548, 1987
Cooper JA, Hunter T: Changes in protein phosphorylation in Rous sarcoma-virus-transformed chicken embryo cells. Mol Cell Biol 1: 165–178, 1981
Cooper JA, Sefton BM, Hunter T: Detection and quantification of phosphotyrosine in proteins. Methods Enzymol 99: 387–402, 1983
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Bourassa C, Chapdelaine A, Roberts KD, Chevalier S: Enhancement of the detection of alkali-resistant phosphoproteins in polyacrylamide gels. Anal Biochem 169: 356–362, 1988
Polychronakos C, Piscina R, Fantus IG: Enhancement of cytosolic tyrosine kinase activity by propylthiouracil-induced hyperplasia in the rat thyroid. Endocrinol 124: 505–510, 1989
Blackshear PJ, Nemenoff RA, Avruch J: Characterization of insulin and epidermal growth factor stimulation of receptor autophosphorylation in detergent extracts of rat liver and transplantable rat hepatoma. Endocrinol 114: 141–152, 1984
Durocher Y, Chapdelaine A, Chevalier S: Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145. Cancer Res 49: 4818–4823, 1989
Wells A, Bishop JM, Helmesti D: Amplified gene for the EGF receptor in a human glioblastoma cell line encodes an enzymatically inactive protein. Mol Cell Biol 8: 4561–4565, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Durocher, Y., Chevalier, S. Protein tyrosine kinases in human breast cancer: Kinetic properties and evidence for the presence of two forms of native enzyme. Breast Cancer Res Tr 17, 99–107 (1990). https://doi.org/10.1007/BF01806290
Issue Date:
DOI: https://doi.org/10.1007/BF01806290